[{"Assets_0_Q2_USD":14428700000.0,"CIK":"872589","Country":"United States","EarningsPerShareBasic_1_Q2_USD":8.19,"EarningsPerShareBasic_2_Q2_USD":13.87,"EarningsPerShareDiluted_1_Q2_USD":7.61,"EarningsPerShareDiluted_2_Q2_USD":13.03,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"77738004554.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":1641400000.0,"NetIncomeLossConverted_1_Q2_USD":897300000.0,"NetIncomeLossConverted_2_Q2_USD":1521900000.0,"OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","RevenuesConverted_1_Q2_USD":1952000000.0,"RevenuesConverted_2_Q2_USD":3780200000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q2_USD":9057400000.0,"Ticker":"REGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":117900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":116800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":109600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":109700000.0,"filed":"20200805","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2020.0","name":"REGENERON PHARMACEUTICALS, INC.","period":"20200630","qtrs":"1","uom":"USD"}]